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Daniel Lopata 
 
Bowman v. Monsanto: Agriculture’s Implications for…technology? 
 
I. Introduction 
 The decision in the agricultural battle between Monsanto and Bowman has implications 
beyond agriculture.  Experts in the technology sector are observing the decision the Supreme 
Court is set to issue soon. That very decision will decide the path that software and technology 
will take to protect any infringement of their intellectual property.  The agricultural 
biotechnology giant Monsanto is once again embroiled in a lawsuit, this time against seventy-
five year old Indiana farmer Hugh Bowman.  Monsanto is accusing Bowman of infringing on its 
genetically modified seed patents.  Bowman allegedly used second-generation seeds to plant his 
crops for a period of eight years.  The company says that by not buying seeds for each generation, 
Bowman violated its patents and the technology Monsanto has with Bowman.  
 Bowman is arguing that the patent exhaustion doctrine should apply. Bowman purchased 
the patented seeds from a third party; specifically, a grain elevator. Bowman’s legal team claims 
that Monsanto does not have patent rights in the resale of its product from a third party. The 
doctrine is derived from old common law cases, to be discussed below; there judges found that a 
resale of an item exhausts or extinguishes a patent owner’s rights in the intellectual property. 
 The implications for each side are huge. A victory for Monsanto would secure its patents 
against other infringers who similarly use Monsanto’s self replicating generation seeds and 
strengthen its position as the primary supplier of agricultural products. A victory would 
strengthen Monsanto’s position since now every supplier of Monsanto’s patented seeds and 
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every purchaser would be required to remit royalty payments to Monsanto. A victory for 
Bowman would ensure that companies find alternative methods to protect their intellectual 
property; companies may resort to the development of terminator technology as a result of a 
Bowman victory. Terminator technology ensures that seeds would not be able to produce 
second-generation offspring. Currently, Monsanto rejected the use of terminator seeds. The 
ramifications of Bowman’s victory would also spill over into software, where technology firms 
are concerned that a Supreme Court decision in favor of Bowman would facilitate software 
piracy. 
 Both Bowman and Monsanto argued their respective points before the Supreme Court in 
February. During oral argument, the Supreme quickly jumped on Bowman’s attorney mere 
seconds into his argument. The Supreme Court concerned itself and Bowman’s attorney with the 
question as to what motivation would intellectual property producers have to develop new 
technologies and even bother patenting them if their rights evaporate so quickly. Shortly 
thereafter, members of the Supreme Court openly stated, in a matter of fact way, that Bowman 
openly infringed Monsanto’s patent. While questioning is often inconclusive and it is impossible 
to predict the Supreme Court’s determination, it appears from oral argument that Bowman’s ship 
is quickly sinking. In turn, technology patent owners are rejoicing.  
 
II. Science Behind Genetic Modification 
While information on the history of early genetic modification is sparse, it is historically 
known that humans have played a role in plant and animal breeding since they made a transition 
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from the hunter-gatherer societies to the Neolithic domestication period around 10,000 B.C.
1
 
According to a study of early man by Australia National University’s academic historian 
William Gammage, people selectively bred animals such as dogs on their farms.
2
  Humans 
selectively bred other animals for their diets and chose plants that produced a favorable yield in 
the conditions in which they lived.
3
 This allowed people to have more prosperous harvests and 
increased their chances of having food, which hunting did not offer.
4
  
If we fast-forward to modern times, we see that the origins of genetically modified 
organisms began with the discovery of DNA and the understanding of recombinant DNA. The 
pairing of bases in DNA, which was brought to light by Watson and Crick in 1953
5
, provided a 
clear mechanism of the methodology that organisms use to copy their genetic information.
6
 
Without this vital piece of information, scientists such as Paul Berg, who in 1972 created the first 
recombinant DNA molecule by combining genes from two different virus organisms, would not 
have otherwise been possible.
7
  
 Once scientists were able to discover the model and basis for DNA, they were able to 
alter the instructions of any cell and organism that they needed to.
8
 Thus, they engineered plants 
                                                 
1
 WILLIAM GAMMAGE, LONDON PAPERS IN AUSTRALIAN STUDIES 1-27 (Menzies Centre for 
Australian Studies eds., 2005). 
2
 Id. 
3
 Id. 
4
 Id. 
5
 The Discovery of the Molecular Structure of DNA - The Double Helix, available at 
http://www.nobelprize.org/educational/medicine/dna_double_helix/readmore.html?referer=www
.clickfind.com.au (last visited Mar. 21, 2013). 
6
 Id. 
7
Id. 
8
 National Human Genome Research Institute (NHGRI), Deoxyribonucleic Acid, available at 
http://www.genome.gov/25520880 (last visited Mar. 21, 2013). 
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to have the traits that were desirable for Monsanto.
9
 A cell that is genetically modified will pass 
on those traits to its offspring just as any other cell would because the instructions that were 
programmed into the DNA are part of the organism.
10
 
 The DNA molecule or deoxyribonucleic acid molecule contains instructions and both are 
passed down from the previous generation to the next. During the process of replication as well 
as protein synthesis, the DNA molecule unwinds from its tightly wound form from within the 
nucleus, exposing the sequence which instructs the cell to perform the required process. The 
DNA molecule is composed of varying sequences of nucleotides, which contain one of four 
nitrogenous bases called adenine, thymine, guanine, and cytosine.
11
 In addition to a base, the 
nucleotide contains a phosphate group and a deoxyribose sugar group on the outside of the 
base.
12
 The nucleotide is considered to be a building block of the genome because it is a 
component of the instructions for the organism.
13
 Each sequence of the nucleotides containing 
the different bases has different instructions for every individual organism.
14
 Two chains of 
nucleotides join together to form a double helix with the attaching bases being complimentary to 
each other.
15
 The adenine joins the thymine and the guanine joins the cytosine.
16
 The double 
helix of the DNA is like a winding ladder, and this trait contributes to the DNA’s ability to pass 
instructions to the next generation and or create a protein.
17
 A single complementary base pair 
                                                 
9
 History of Monsanto Corp., available at 
http://www.monsanto.com/whoweare/Pages/monsanto-history.aspx (last visited Mar. 21, 2013).  
10
 NHGRI, supra note 8. 
11
 Id. 
12
 Id. 
13
 Id. 
14
 Id. 
15
 Id. 
16
 Id. 
17
 Id. 
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can be likened to that of a single step of the ladder.
18
 The complementary pairs are joined by 
either two or three hydrogen bonds.
19
 The cytosine and guanine are bonded together via three 
hydrogen bonds and have a stronger link together than the two hydrogen bonds that keep adenine 
and thymine bonded.
20
 
 The two chains of the helix run in opposite directions and are anti-parallel.
21
 One side 
runs in the five prime to three prime direction, while the complimentary strand runs the same, but 
in the opposite direction.
22
 The three and five indicate the directions in which the carbons on the 
sugars face.
23
 A phosphodiester linkage connects the sugars of the DNA to each other, which is a 
phosphate group that connects the third carbon on one nucleotide to the fifth on the next sugar. 
24
 
Yet, only one strand can be used as a template strand during the process of proteins synthesis.
25
  
It is from that strand and not its complimentary one that DNA is transcribed into mRNA, which 
is used to construct proteins.
26
 This process requires great precision because there are twenty 
different amino acids that can be used to make up the protein.
27
 
These revolutionary ideas were the predecessor for and allowed the US to have the ability 
to mass-produce and sell the first genetically modified crops called the Flavr-Savr tomatoes in 
                                                 
18
 Id. 
19
 Id. 
20
 Id. 
21
 Id. 
22
 University of Illinois at Chicago, DNA Structure, available at 
http://www.uic.edu/classes/phys/phys461/phys450/ANJUM04/ (last visited Mar. 21, 2013). 
23
 Id. 
24
 Id. 
25
 Id. 
26
 NHGRI, supra note 8. 
27
 Id. 
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1994.
28
 These tomatoes synthesized less products that otherwise would cause them to spoil in 
shorter periods of time.
29
 Although China preceded the US in releasing a transgenic crop to the 
masses since the 1980s, today, America is the market leader in genetically engineered 
agricultural products.
30
 Countries worldwide purchase and grow transgenic seeds from 
companies like Monsanto. These genetically modified crops include, but are not limited to: 
insecticide sweet corn, which produces a toxin that eliminates the need for insecticide spraying, 
golden rice, which contains beta-carotene that is essential for the human body to make vitamin 
A, as well as potatoes, among many others that people include in their diets each day.
31
 
The process of genetically engineering seeds is a complex one, but it begins with the 
simple step of isolating a desired trait to incorporate into a plant.
32
 After one obtains the desired 
trait, the goal is to incorporate the novel gene into the genome of the plant seed.
33
 This can be 
done via several different methods. One way of doing this is by implementing the gene gun, 
which shoots fragments of desired DNA sequences using a .22-caliber charge with the DNA 
covering a particle of metal.
34
 Companies may implement another method that uses heat to make 
the seeds vulnerable to Agrobacterium tumefaciens.
35
 Scientists use this organism to incorporate 
                                                 
28
 Food and Water Watch, Genetically Engineered Food, available at 
http://documents.foodandwaterwatch.org/doc/GeneticallyEngineeredFood.pdf, (last visited Mar. 
21, 2013). 
29
 Id. 
30
Genetic Modification Education, A Brief History of Genetic Modification, available at 
http://www.gmeducation.org/faqs/p149248a%20brief%20history%20of%20genetic%20modifi
cation.html (last visited Mar. 21, 2013). 
31
 Bionet, 4 Examples of Genetically Modified Crops, available at 
http://www.bionetonline.org/english/content/ff_cont3.htm (last visited Mar. 21, 2013). 
32
 Rebecca Boyle, How to Genetically Modify a Seed, Step by Step, POPSCI (Jan. 24, 2011, 2:56 
PM), available at http://www.popsci.com/science/article/2011-01/life-cycle-genetically-
modified-seed (last visited Mar. 21, 2013). 
33
 Id.  
34
 Id. 
35
 Id. 
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novel genes into the plant’s genome.36 The benefit of implementing this method is that it is able 
to evade the plant’s natural defenses, and the seed will recognize the novel gene as part of its 
genetic makeup.
37
 Future seeds that will come from this altered seed will possess the new trait 
that the scientists have incorporated into the plant.
38
 
In the case of the disputed Roundup Ready soybean seeds produced by Monsanto, 
scientists discovered a gene in a soil agrobacterium CP4 strain called the CP4 EPSPS gene 
located near their factory in St. Louis, Missouri.
39
 The bacterium has 5-enolpyruvoyl-shikimate-
3-phosphate synthetase (EPSPS), which is an enzyme that provides resistance against glyphosate 
found in Roundup.
40
 The scientists then cloned the gene found in these organisms using 
Escherichia coli in order to increase their numbers.
41
 Finally, they used A. tumefaciens to insert 
the desired isolated gene into the soybean seed genome along with a promoter to aid in 
recognition and copying of the genetic information by the seed’s natural mechanisms.42 This 
completes the work done by the company, but it is up to the seeds to continue the work from 
there. 
Once the scientists obtain the desired sequence, the seed takes over upon planting and 
performs two important steps in order to regulate the plant’s behavior in the growth and 
maintenance of its life.
43
 They are the transcription and translation of the genetic sequence 
                                                 
36
 Id. 
37
 Id. 
38
 Id.. 
39
 International Service for the Acquisition of Agri-Biotech Applications (ISAAA), Roundup 
Ready Soybean, available at http://www.webcitation.org/60hS1x2BS (last visited Mar. 21, 2013).  
40
 Jeremy McDermott, New Super Strain of Coca Plant Stuns Anti-Drug Officials, The Scotsman 
(Aug. 8, 2004, 12:56 AM), available at http://www.scotsman.com/news/international/new-super-
strain-of-coca-plant-stuns-anti-drug-officials-1-550814 (last visited Mar. 21, 2013). 
41
 Boyle, supra note 32. 
42
 ISAAA, supra note 39. 
43
 Id. 
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necessary for producing needed proteins. The plant’s modified DNA is the instruction guide, 
which directs the plant to make necessary proteins for the plant to function properly.
44
 Yet, the 
DNA needs to be transcribed or copied into a temporary form of RNA called mRNA or 
messenger RNA.
45
 This is done using an enzyme called an RNA polymerase, which forms the 
sequence of mRNA.
46
 In order for this to occur, the transgenic seeds use Monsanto’s 35S 
promoter from the Cauliflower mosaic virus (CaMV) in order to activate foreign genes, which 
were inserted from the A. tumefaciens into the soybean seed.
47
 The benefit of implementing 
CaMV promoter is that it can transcribe the whole genome and leads to high levels of gene 
expression in soybean plants.
48
 This results in the incorporation of genetic information that codes 
for EPSPS. Transcription is followed by a step called translation. In this process, the ribosome 
within the plant cell reads the mRNA, which dictates the exact amino acids that are to be 
assembled to form a protein.
49
 If there is no protection against the glyphosate toxin, also known 
as N-phosphonomethylglycine by its chemical name, the plant would be unable to perform these 
necessary steps to produce proteins.
50
 The EPSPS is essential in producing resistance in crops 
against the glyphosate in the Roundup herbicide intended to kill weeds.
51
 Without this protection, 
it would normally kill soybean crops after contact with the toxin.
52
 This allows the farmers to 
                                                 
44
 Id. 
45
 Id. 
46
 Id. 
47
 Id. 
48
Wei Pelechano, Al Jaervelin, and Lars Steinmetz, Functional Consequences of Bidirectional 
Promoters, US National Library of Medicine (May 24, 2011), available at  
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123404 (last visited Mar. 21, 2013). 
49
 ISAAA, supra note 39. 
50
 Id. 
51
 Herbicide Tolerance and GM Crops (Jun. 2011), available at 
http://www.greenpeace.org/international/Global/international/publications/agriculture/2011/363
%20-%20GlyphoReportDEF-LR.pdf (last visited Mar. 21, 2013). 
52
 Id. 
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prevent weeds from infesting their fields because they are able to continue implementing their 
desired herbicide.
53
 They can also protect their crops at the same time without losing money and 
crops to the herbicides.
54
  
 
III. Applicable Patent Law 
 A. Statutory Law and Common Law 
 In the United States, patent law is codified under Title 35 U.S.C. §101 et seq. Patent law 
is authorized by the United States Constitution from Article One, section 8(8), which reads [t]he 
Congress shall have power...To promote the progress of science and useful arts, by securing for 
limited times to authors and inventors the exclusive right to their respective writings and 
discoveries.
55
  
 Title 35 is split into four parts with numerous additional provisions allocated within each 
part. The first part establishes the United States Patent and Trademark Office (USPTO) and 
authorizes the USPTO to grant and issue patents and register trademarks.
56
 The second part 
governs what is patentable and what requirements a particular invention must meet to be eligible 
to receive a patent.
57
 The third part deals with the protection of patents and holder’s rights.58 The 
fourth part concerns itself with the Patent Cooperation Treaty; an international document to 
protect patents rights oversees.
59
 However, Bowman v. Monsanto involves a principle not found 
codified in in Title 35. Patent owners generally have the entire statutory patent term, currently set 
                                                 
53
 ISAAA, supra note 39 
54
 Id. 
55
 U.S. Const. article 1, § 8, cl. 8. 
56
 35 U.S.C. §§ 1–42 (2012) 
57
 35 U.S.C. §§ 100-212 (2012). 
58
 35 U.S.C. §§ 251–329 (2012). 
59
 35 U.S.C. §§ 351–376 (2012). 
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at 20 years from filing under 35 U.S.C. §154(a)(2), over which to recover their research and 
development costs. 
 A modern U.S. patent consists of two basic parts: a specification and one or more 
claims.
60
 The specification portion includes a written description and diagram with information 
depicting the proposed patent.
61
 The specification and diagram describe the proposed patent and 
serves to inform those proficient in the particular area of the proposed patent on how to utilize 
the invention.
62
 The final sentences of the proposed patent end with one or more claims about the 
patent
63
, which consist of a single sentence describing what the patent owner defines as the 
patented invention.
64
 The claim must "particularly point out and distinctly claim the subject 
matter which the applicant regards as his invention."
65
 Patent law requires both the specification 
and at least one patent claim.
66
 Once granted by the USPTO, the patent, containing the 
specification and one or more patent claims, becomes publicly available.
67
 
 There are two purposes served by the submission of a patent claim to the USPTO. First, the 
claim acts as a notice function.68 The claim puts the entire world on notice about what is seeking to be 
patented and by whom.69 The claim seeks to inform the public of the exact scope ofexclusivity granted 
by the patent.38 Second, the patent claim performs a substantive function that goes beyond what is 
available to the public.70 The patent claim uses patent law to define the scope of protection that is 
                                                 
60
 35 U.S.C. § 112 (2012). 
61
 Id. 
62
 Id. 
63
 Id. 
64
 Id. 
65
 Id. 
66
 Id. 
67
 35 U.S.C. § 122(b)(1) (2012). 
68
 Texas Digital Sys. Inc. v. Telegenix, Inc., 308 F.3d 1193, 1202 (Fed. Cir. 2002). 
69
 Id. 
70
 Aro Mfg. Co. Inc. v. Convertible Top Replacement Co., 365 U.S. 336, 339 (1961). 
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being sought.71 This functions to outline the subject matter that only the patentee may practice.72 
Therefore, submission of a patent claim performs both definitional and public-notice functions. 73 
 That being said, a significant part of Bowman v. Monsanto involves the common law 
theory of exhaustion rights, otherwise known as the first sale doctrine. The Supreme Court first 
recognized the patent exhaustion doctrine in 1873 in the seminal case of Adams v. Burke.
74
 This 
common law patent doctrine represents the proposition that once an unrestricted authorized sale 
of the patented material occurs, the patent holder’s exclusive right to control the subsequent use 
and sale of that article is gone, or exhausted.
75
 An unrestricted authorized sale is defined as a sale 
where the patent holder cannot suppress the sale of the item.
76
 In other words, since the patent 
holder no longer has rights to the patented device, the purchaser of the patented material is free 
to use or resell the patented material without consideration of the patent holder’s rights in that 
article.
77
 Under the current state of the law the purchaser is expressly forbidden from re-growing 
or re-creating the patented article, unless specifically authorized by the patent holder.
78
 With the 
first unrestricted sale of a patented article, the patent holder’s voluntary introduction of that into 
commerce prevents the patent holder from exercising his or her right to exclude others from 
using or reselling the patented material.
79
 
                                                 
71
 Id. 
72
 McClain v. Ortmayer, 141 U.S. 419, 424 (1891). 
73
 Texas, supra note 68. 
74
 Adams v. Burke, 84 U.S. 453 (1873) 
75
 Monsanto Co. v. Scruggs, 459 F.3d 1328, 1336 (Fed. Cir. 2006). 
76
 Interdigital Technology Corp. v. OKI America Inc., 803 F.2d 684, 687 (Fed. Cir. 1986). 
77
 Scruggs, supra note 75. 
78
 Id. 
79
 United States v. Univis Lens Co., 316 U.S. 241, 251 (1942). 
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 There are two important limitations of the patent exhaustion doctrine. The first limitation 
is the sale of an incomplete article.
80
 An incomplete article is one that is a component of a greater 
part. For example, in Univis Lens, the court held that a single lens blank that was used in 
producing more lenses was incomplete.
81
 In these situations, exhaustion is applicable to the 
authorized sale of an incomplete article if: (1) its “only reasonable and intended use was to 
implement the patent, and (2) it “embodies essential features” of the patented invention.82 For 
example, in Quanta Computer, the court said that patented LG components in Intel processors 
were useless without connecting them to other components, which is what Quanta did.
83
  In 
clearer language, the supplier of components of cannot claim patent rights in the finished 
device.
84
 
 The next significant limitation is known as the sales limitation. The body of law setting 
forth the scope of this limitation restricts the sale or use of the patented material beyond the first 
sale when the patented material is actually in the possession of the customer or purchaser of the 
patented material.
85
 In addition to being found in Monsanto’s technology agreement, this 
limitation is commonly seen in software agreements. This limitation arose in the 1992 case of 
Mallinckrodt, Inc. v. Medipart.
86
 Unfortunately, the extent of this limitation is unclear under 
current law. Bowman v. Monsanto should be the deciding case whether Mallinckrodt is still good 
law.  
 B. Case law 
                                                 
80
 Id. 
81
 Id. 
82
 Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617, 631-32 (2008). 
83
 Id. 
84
 Id. 
85
 General Talking Pictures Corp. v. Western Electric Co., 304 U.S. 175 (1938). 
86
 Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700 (Fed. Cir. 1992). 
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 A number of cases were brought up above relevant to the law at issue in Monsanto v. 
Bowman. This section will introduce the facts and holdings of several key cases.  
 The first to be discussed is Monsanto Co. v. Scruggs, 459 F.3d 1328 (Fed. Cir. 2006). 
Scruggs has facts closely relating to the facts in the instant case of Bowman v. Monsanto. Like in 
Bowman, Monsanto licensed the patents for herbicide and insecticide resistant soybeans to seed 
companies.
87
 Under the license agreement, those seed companies were permitted to incorporate 
the genetic material into their own germplasm to produce herbicide resistant and insect resistant 
seeds.
88
 The licensing agreement also had a provision that the seed companies could sell the 
resulting genetically modified seeds only to farmers who entered into license agreements with 
Monsanto.
89
 Additionally, the license agreements with farmers prohibited the farmers from 
replanting the genetically modified seed from the crops grown.
90
 
 The defendant, Scruggs, a farm limited liability company run by its namesake farmer and 
his family, bought seeds containing Monsanto’s patented technology but never signed the license 
agreement.
91
 Scruggs planted the first generation seeds, and then replanted the second-generation 
seeds after the first harvest.
92
 Scruggs did not sell any of the seeds.
93
 Monsanto then sued 
Scruggs for infringing on its herbicide and insecticide patent.
94
 Scruggs denied any infringement 
and argued that the patents at issue were invalid.
95
 Scruggs also retaliated with antitrust and 
                                                 
87
 Scruggs, supra note 75. 
88
 Id. 
89
 Id. 
90
 Id. 
91
 Id. 
92
 Id. 
93
 Id. 
94
 Id. 
95
 Id. 
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patent misuse claims.
96
 Scruggs also denied infringement and claimed that the patents at issue 
were invalid. The trial court granted summary judgment on all issues for Monsanto, and the 
Federal Circuit affirmed on most of the issues.
97
 
 Part of the argument in the Scruggs case was the exhaustion doctrine.
98
 Scruggs argued 
that argued that he purchased the Monsanto seeds in an unrestricted sale, and that he was 
therefore entitled to use those seeds in an unencumbered fashion under the doctrine of patent 
exhaustion.
99
 Scruggs claimed that under the doctrine of patent exhaustion, he could use or sell 
the purchased seeds in whatever fashion he wanted.
100
 Unfortunately for Scruggs, the court 
quickly rejected his argument.
101
 The court stated that the doctrine was inapplicable in that 
case.
102
 The court went on to say “[t]here was no unrestricted sale because the use of the seeds by 
seed growers was conditioned on obtaining a license from Monsanto. Furthermore, the ‘first sale’ 
doctrine of exhaustion of the patent right is not implicated, as the new seeds grown from the 
original batch had never been sold.”103 Thus, it appears that unless there is an actual sale of the 
second-generation seeds, the patent exhaustion doctrine is not implicated. Merely being able to 
replicate a patented technology does not give the copier a right to use that replicated 
technology.
104
 The Scruggs court was aware that opening the floodgates by applying the 
                                                 
96
 Id. 
97
 Id. 
98
 Id. 
99
 Id. at 1336. 
100
 Id. 
101
 Id. 
102
 Id. 
103
 Id. 
104
 Id. 
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exhaustion doctrine to subsequent generations of self-replicating technology would kill the rights 
of the patent holder.
105
 
 The next case to tackle is Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617 
(2008). In that case, LG, an electronics manufacturer, owned several patents on methods and 
systems for processing information.
106
 LG then entered into several agreements with Intel, a 
major computer component manufacturer and developer.
107
 Embodied within the agreement, 
Intel would be permitted to use LG’s patents in creating and selling its microprocessors.108 Also 
writing into the agreement, LG included a provision that its patent would not be exhausted in 
subsequent sales of Intel processors using LG’s patented methodology.109  
 Quanta, the world’s largest manufacturer of laptops and hardware, purchased Intel 
processors and included them in its computers.
110
 In incorporating Intel processors in its 
machines, Quanta used LG’s patented methodology, since that was the only way Intel designed 
its processors to be included in computers.
111
 Unfortunately, the record is sparse with facts and 
information, apparently in an attempt to protect trade secrets. Regardless, LG sued Quanta for 
violating its patents.
112
 
 In trial court, Quanta prevailed on the patent exhaustion claims.
113
 In federal court, the 
court reversed the patent exhaustion claims.
114
 The Supreme Court reversed the federal court, 
                                                 
105
 Id. 
106
 Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617 (2008). 
107
 Id. 
108
 Id. 
109
 Id. 
110
 Id. 
111
 Id. 
112
 Id.  
113
 Id. 
114
 Id. 
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and allowed Quanta’s patent exhaustion claim.115  The court found that all the patents were 
already incorporated into the Intel microprocessors, which embody the essential features of the 
patents because they carry out all the inventive processes when combined with standard 
components.
116
 In effect, the court stated that LG’s patent was exhausted when Intel sold its 
processor to Quanta.
117
  
 The next significant case is United States v. Univis Lens Co., 316 U.S. 241 (1942). In 
Univis, the Univis Lens Company owned method and product patents on optical lenses.
118
 Univis 
developed lens blanks, which would then be sold and ground and polished to become the final 
patented product.
119
 The final product was then sold at prices that were fixed by Univis.
120
 The 
entire point of selling the blanks was to manufacture the patented lenses.
121
 The court held that 
the exhaustion doctrine exhausted the patent protection of the blanks.
122
 The court wrote that the 
patent is exhausted “[w]hether the licensee sells the patented article in its completed form or sells 
it before completion for the purpose of enabling the buyer to finish and sell it.”123 The Univis 
case has been upheld in later decisions such as Quanta.
124
 
 
IV. Bowman vs. Monsanto  
a. Facts 
                                                 
115
 Id. 
116
 Id. 
117
 Id. 
118
 Univis, supra note 79. 
119
 Id. 
120
 Id. 
121
 Id. 
122
 Id. 
123
 Id. at 244. 
124
 Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617 (2008). 
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 Monsanto Company (“Monsanto”) is a publicly traded American agricultural 
biotechnology corporation headquartered in Missouri. Monsanto is one of the leading producers 
of genetically engineered seeds and herbicides. In 1983, Monsanto was one of the first 
companies to create a genetically modified plant cell.
125
 Four years later, in 1987, the company 
was able to actually conduct field trials using its genetically modified seeds.
126
 The first field 
trials used soybeans with Roundup Ready resistance.
127
 
 Monsanto’s business model focuses heavily on research and development.128 Through 
heavy spending on researching and developing new products, the company develops herbicides 
and patents genetically modified seeds.
129
 The company then recovers its costs from the sale of 
its products to the agricultural sector and strict enforcement of its patents.
130
 Due to Monsanto’s 
austere enforcement measures, farmers and advocates have heavily criticized the company.
131
  
 Monsanto is known as the firm that designs herbicide resistant soybeans, which are called 
“Roundup Ready”, due to the soybeans’ resilience to Roundup, an herbicide created by the 
company.
132
 The two patents at issue, Patent No. 5,352,605 ("605") and Patent No. RE39, 247 
                                                 
125
 Colorado State University, available at http://cls.casa.colostate.edu/transgeniccrops/how.htm 
(last visited Mar. 21, 2013). 
126
 History of Monsanto Corp., available at 
http://www.monsanto.com/whoweare/Pages/monsanto-history.aspx (last visited Mar. 21, 2013). 
127
 Id. 
128
Keith Schneider, Betting the Farm on Biotech (Jun. 10, 1990), available at 
http://www.nytimes.com/1990/06/10/magazine/betting-the-farm-on-
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("247E"), involve different parts of the herbicide resistance technology.
133
 The 605 patent applies 
to a process by which Monsanto combined two different sequences of DNA to create a new gene 
called a chimeric gene.
134
 These chimeric genes then give the plant new characteristics, such as 
herbicide resistance.
135
 The 247E patent uses the process in the 605 patent to create chimeric 
genes in soybean plants that makes them compatible with herbicides.
136
 
 Monsanto sells these herbicide resistant soybeans to suppliers and licenses the herbicide 
resistance technology to seed producers.
137
 In their Technology Agreement, Monsanto limits the 
use of their seeds and technology to a single season and prohibits supplying it to a third party or 
replanting second generation seeds.
138
 Second generation seeds are the product of soybean plants 
grown from original seeds.
139
 Although the Agreement generally prohibits growers from selling 
second-generation seeds for replanting, Monsanto does allow growers to sell them to local grain 
silos to be used as animal feed or to be sold as a commodity.
140
 Commodity seeds are a 
collection of many different types of seeds from local growers that are purchased for a variety of 
uses, such as livestock feed.
141
 
 Under the agreement, the licensed grower or farmers agree to a number of provisions.
142
 
The first relevant provision is to use the seed with Monsanto’s patents for planting a commercial 
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crop for only a single season.
143
 Second, the licensee agrees to not supply the seed to anyone else 
for planting.
144
 Third, the licensee agrees that it will not save any crops produced from 
Monsanto’s seed for replanting or share the saved seed with anyone else for replanting.145 Fourth, 
no one shall use this seed for crop breeding, research, or seed production.
146
 As mentioned before, 
Monsanto does permit licensees to sell the second generation of the seeds for commodity 
purposes.
147
  
 At issue in Monsanto v. Bowman, Indiana farmer Vernon Hugh Bowman purchased 
seeds from Pioneer, a registered seed producer of Monsanto.
148
 As required by Monsanto, 
Pioneer had Bowman sign an agreement identical to Monsanto’s Technology Agreement, which 
limited the use of the seeds to a single season and mandated that Bowman comply with 
Monsanto’s terms and conditions. 149  Monsanto also sent Bowman a letter directly, which 
informed Bowman that he could not replant any form of Monsanto’s herbicide resistant seeds.150 
Bowman regularly purchased seeds from Pioneer from approximately 1999 until 2007.
151
 In 
following the terms and conditions of the agreement with Monsanto and Pioneer, Bowman did 
not save his seeds from the first planting or in any subsequent year.
152
  
 In 1999, Bowman also purchased seeds from a local commodity seed provider, who sold 
seeds for solely for the purpose of feed, not planting, and planted a second crop against the terms 
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and conditions of Monsanto.
153
 Since Bowman considered the second-crop to be a higher risk for 
planting, he purchased the commodity seed from the grain elevator to avoid paying the 
significantly higher price for Roundup Ready seeds.
154
 That same year, Bowman applied the 
Roundup herbicide to the fields in which he had planted the second-hand grain elevator seeds to 
control weeds and to determine whether the plants would exhibit herbicide resistance.
155
 He 
confirmed that many of the plants were, indeed, resistant.
156
 Thereafter, with each subsequent 
year, from 2000 through 2007, Bowman treated his second crop with Roundup herbicide.
157
 With 
this second crop, Bowman saved the seed harvested for replanting additional second crops in 
later years.
158
 He also supplemented his second crop planting supply with additional purchases of 
commodity seed from the grain elevator.
159
 Bowman did not attempt to hide his activities, and he 
candidly explained his practices with respect to his second-crop soybeans in various 
correspondences with Monsanto’s representatives between 2006 and 2007.160 
 In winter of 2006, Monsanto became aware of Bowman’s planting practices and 
investigated his use of herbicide resistant seeds.
161
 Monsanto investigated eight fields that 
Bowman owns, totaling approximately 299 acres and confirmed that the second crop seeds that 
Bowman was planting contained their Roundup Ready gene.
162
 Upon confirmation that 
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Bowman’s second crops displayed herbicide resistance, Monsanto sued him for patent 
infringement of its 605 and 247E patents.
163
 
b. Procedural History 
 In the Federal District Court, the Southern District Court of Indiana dismissed Bowman’s 
claims on summary judgment.
164
 Bowman brought a defense of patent exhaustion and that 
Monsanto failed to provide actual notice of infringement to him.
165
 The court found Bowman’s 
argument compelling, yet decided that the case relied on by Bowman, Scruggs
166
, was 
distinguishable from Bowman’s situation.167 In Bowman’s case, there was a license agreement 
that Monsanto had him sign whereas there was no license agreement in Scruggs or the other 
cases Bowman relied on.
168
 The court additionally made a policy judgment that agreeing with 
Bowman would eviscerate patent holders’ rights in their technology and hard work. 169 
Furthermore, the court held that the patent exhaustion is inapplicable.
170
 Bowman argued that the 
seeds from one generation are identical to the next generation, thus adopting a robust exhaustion 
doctrine that encompasses the progeny of seeds and other self-replicating technology.
171
 
Monsanto counters this by arguing that the seeds are governed by the technology agreement and 
are not intended for planting.
172
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 The Court of Appeals for the Federal Circuit found that Monsanto’s patent rights in the 
seeds were not exhausted once sold to a commodity dealer.
173
 The Federal Circuit further 
reasoned that although Monsanto’s patented technology can replicate itself, a buyer could not use 
the product of replication because it would eliminate Monsanto’s patent rights.174 The court 
concluded that Bowman retained the right to sell second-generation seeds as feed or for any 
other number of uses, but he was prohibited from replanting them in any form.
175
 
 On December 20
th
, 2011, Petitioner Hugh Bowman filed a writ of certiorari to the United 
States Supreme Court. After both sides filed supporting and opposing briefs, with twenty-five 
amicus briefs filed
176
, the Supreme Court granted the writ of certiorari on October 12, 2012.
177
 
On February 19, 2013, oral arguments were heard before the Supreme Court.
178
 As of this 
writing, a decision is still pending with an uncertain release date.
179
 
 During oral argument, the court hinged on why anyone would want to develop patents if 
they would lose rights to them after the first generation.
180
 Good answers to that question would 
be to use contract law to supplement patent law and to argue that not all seeds are fungible. The 
second argument is exactly what Bowman’s counsel replied to the court.181 Next, the court 
inquired as to whether the exhaustion doctrine even applies. The court stated that the law never 
allows one to make a copy of the seed and use it without a license, since the progeny would be a 
                                                 
173
 Id. 
174
 Id. 
175
 Id. 
176
 SCOTUS Blog, available at http://www.scotusblog.com/case-files/cases/bowman-v-
monsanto-co/ (last visited Mar. 21, 2013). 
177
 Id. 
178
 Id. 
179
 Id. 
180
 Bowman v. Monsanto Co. Official Transcript (Feb. 19, 2013), available at 
http://www.supremecourt.gov/oral_arguments/argument_transcripts/11-796.pdf (last visited Mar. 
21, 2013). 
181
 Id. 
 23 
new item.
182
 In reference to Buck v. Bell, Justice Breyer humorously replied, “three generations 
of seed are enough.”183 Bowman’s lawyer answered the inquiry into the exhaustion doctrine by 
replying that this is a new case involving the exhaustion doctrine with self-replicating 
technology.
184
 
V. Implications for Software 
 The question in Bowman v. Monsanto involves second-generation seeds that were not the 
subject of an authorized sale. As the court of appeals correctly concluded, once a grower, such as 
Bowman, plants the commodity seeds that contain Monsanto’s Roundup Ready technology and 
the next generation of seed develops, the grower has created a newly infringing article. 
 Any tampering with patent rights in Bowman v. Monsanto would effectively shorten the 
patent term for patents covering artificial, software, biotechnology, and progenitive technologies, 
thus making it much more difficult, if not impossible, for patent owners and their licensees to 
recover the costs of development and research for the market. This would reduce or perhaps 
eliminate any incentive for innovation of new software, biotech, or progenitive technologies. The 
public and private sectors would certainly be harmed under this scenario. To recoup its costs, 
software companies would have to drastically increase the prices at a level unaffordable to many 
consumers.  
 Bowman cannot persuasively argue that he did not plant the second generation of seeds. 
Certainly there is no reason that one action cannot simultaneously use a patented good and make 
another patented article. Similarly, Bowman is wrong in contending that, because the self-
replication of the first-generation seeds is a consequence of their normal use, that he may use the 
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second-generation seeds, based on an analogy to the Supreme Court’s determination in Quanta 
that the authorized sale of a product exhausts a patent when the only reasonable and intended use 
of the article sold was to practice the patent.
185
  
 To begin with, the question in Quanta involved the use of an article acquired through an 
authorized sale. In Bowman v. Monsanto, the issue relates to a new copy of the patented article. 
Moreover, the court below correctly concluded that there were uses of second-generation soy-
bean seeds other than practicing the patent, namely that those seeds may be used as a commodity 
for feed or food. There simply is no argument that planting is the only reasonable and intended 
use of the second-generation seed copies resulting from the planting of the first-generation seeds. 
 When planted, the initial generation of seeds has become spent. Likewise, the second-
generation seeds qualify as a wholly new article under patent law. Due to the important fact that 
the second-generation seeds were not the subjects of an authorized sale, Bowman’s use of those 
seeds constitutes infringement. 
 Taking this argument a step further, any exception to the conventional exhaustion 
standards for self-replicating seeds should absolutely not extend to computer software. This is 
because Bowman v. Monsanto and the arguments contained within that case hinge on the 
particular features of soybean seeds. With soybean seeds, self-replication is a natural occurrence 
and a feature particular to soybean seeds. The use of computer software typically results in a 
temporary copy of the software on the computer’s random access memory. This is necessary for 
the program to run. Although this appears to be self-replication in a literal sense, it is remarkably 
different. Soybean seeds replicating is a completely natural phenomenon with a singular 
reasonable use. Conversely, computer software replicating is to facilitate the operation of the 
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first-generation of software. The principal purpose of self-replication of software is only to make 
that particular software run. Its purpose is certainly not self-replication. Moreover, a software 
user acquires license to use the software with rights explicitly laid out in the end user license 
agreement, the user has not acquired the software through an authorized sale as required for the 
exhaustion doctrine to apply.  
 
 According to statistics presented by The Software Alliance, the technology industry is 
essential to the modern economy; it has, for example, played a critical role in the recovery from 
the recent recession.
186
 Thus, the Bureau of Economic Analysis estimates that the technology, 
information, and communications sector (which includes computer hardware and software) grew 
by 6.9% in 2011, which accounted for approximately 20% of total national GDP growth that 
year.
187
 
 Moreover, U.S. technology companies are among the nation’s leading exporters of 
products, significantly strengthening the U.S. economy.
188
 Between January and November 2012, 
U.S. companies exported nearly $113 billion of computers and electronic products--about 8% of 
total U.S. exports. U.S. Census Bureau, U.S. International Trade in Goods and Services, FT-900 
Supplement November 2012, at 1 Ex. 1 (2013).
189
 Software products contribute approximately 
$36 billion in annual exports. See Robert W. Holleyman, BSA President and CEO, Testimony 
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before the United States House of Representatives Committee on Energy and Commerce, 
Subcommittee on Commerce, Manufacturing and Trade, at 2 (Mar. 16, 2011).
190
 
 Investment in the technology industry reflects its critical importance to the American 
economy.
191
 In 2008, companies invested approximately $46.9 billion in research and 
development for software and computer-related services--approximately 16% of total industrial 
research and development expenditures for the Nation. Nat’l Sci. Bd., Science and Engineering 
Indicators, at 4-21 & 4-23 (2012).
192
 Companies invested about $45 billion in research for the 
computer and electronic products sector in 2008.
193
 Together, hardware and software account for 
roughly 31% of total spending by businesses on research and development.
194
 Software Alliance 
member companies each year spend in excess of $32 billion on research and development to 
expand their innovation portfolios.
195
 
 Technology firms also are leading innovators. Between 2006 and 2008, 77% of 
companies engaged in software development "report[ed] the introduction of a new product or 
service compared to the 7% average for all nonmanufacturing industries." Nat’l Sci. Bd., supra, 
at 6-47.
196
 Computer manufacturers likewise far outstrip the national average for innovation, 
with over 50% of companies in the hardware market reporting the innovation of a new product or 
service.
197
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 The above statistics serve to highlight the tremendous importance of the software 
industry and the significance of intellectual property protection to software firms. The 
intellectual property protections provided by patent law are therefore critical for innovation. 
Additionally, with patent law left in an uncertain state, an ambiguous decision would subject 
software companies to opportunistic infringement suits. Due to the very high costs of defending 
these lawsuits, companies may choose to settle instead of fighting their battles in court, 
regardless of the merits of the case. The high lawsuit costs inhibit innovation and divert valuable 
resources away from research, development, and production.
198
  
 Technology firms argue that the court above properly concluded that exhaustion doctrine 
does not actually apply in this case. The longstanding doctrine of patent exhaustion provides that 
the initial authorized sale of a patented items terminates all patent rights to that item."
199
 They 
cite to a case on point, namely, United States v. Univis Lens Co., 316 U.S. 241, 251 (1942) ("the 
purpose of the patent law is fulfilled with respect to any particular article when the patentee has 
received his reward for the use of his invention by the sale of the article") (emphases added). 
Additionally, the milestone case of Adams v. Burke provides guidance. In Adams v. Burke
200
, the 
court states that a patent owner who sells a machine or instrument has received all the royalty or 
consideration, which he claims for the use of his invention in that particular machine or 
instrument. An authorized sale of seeds therefore would exhaust the patent rights in the particular 
seeds that were sold. 
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 Piracy is already a scourge on the computer software industry, resulting in losses of $63.4 
billion in 2011.
201
 Any possible legal loophole or strict interpretation of the patent laws to further 
encourage piracy would be devastating. Therefore, it would be folly  
for a case concerning soybean seed patents to affect the viability of a completely different 
industry relying on patents and copyrights. Furthermore, any restriction on a patent holder’s 
rights would naturally lead to the patent holder developing a new way to protect its rights. In the 
case of technology, it is foreseeable that a software firm or hardware firm rely more on contract 
rights through its licensees. Moreover, when it comes to customers attempting to replicate its 
products, software can easily develop a digital distribution model with each user having a unique 
access code to limit piracy. Regardless, the consumers have to pay the price of tighter controls 
over patent holders’ software. To keep things as they are, Bowman simply needs to lose. 
VI. Conclusion 
 Bowman v. Monsanto can determine the fate of other products, such as computer 
software. Although agriculture and computer technology are very different, the concept that is 
being brought to court is a similar one. When people implement computer software, the 
computers create temporary copies of the program. Like the plant seeds, computer software 
would be characterized as self-replicating. If the case were ruled in favor of the farmers, it would 
allow and fuel widespread software piracy. Software users will be able to obtain temporary 
copies and replicate them with the intent to either sell or illegally share online because the court 
ruling will not extend the patent to these copied versions of the original software. Ultimately, 
farmers will not win. The Supreme Court appeared to side in favor of Monsanto during 
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questioning. The court appeared skeptical of letting patent rights lapse and the effects it would 
have on the creation of new patents. Regardless, even if the court some how does find in favor of 
Bowman, farmers and consumers still lose. Monsanto will implement terminator technology. 
Technology would shift to prevent it from being replicated, such as digital distribution with 
unique keys for software. Hardware would be much closely guarded via contract law. The case 
must come out in favor of Monsanto to keep the status quo. 
